Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity
- PMID: 20139279
- PMCID: PMC2935290
- DOI: 10.4049/jimmunol.0903655
Five HLA-DP molecules frequently expressed in the worldwide human population share a common HLA supertypic binding specificity
Abstract
Compared with DR and DQ, knowledge of the binding repertoires and specificities of HLA-DP alleles is somewhat limited. However, a growing body of literature has indicated the importance of DP-restricted responses in the context of cancer, allergy, and infectious disease. In the current study, we developed high-throughput binding assays for the five most common HLA-DPB1 alleles in the general worldwide population. Using these assays on a comprehensive panel of single-substitution analogs and large peptide libraries, we derived novel detailed binding motifs for DPB1*0101 and DPB1*0501. We also derived more detailed quantitative motifs for DPB1*0201, DPB1*0401, and DPB1*0402, which were previously characterized on the basis of sets of eluted ligands and/or limited sets of substituted peptides. Unexpectedly, all five DP molecules, originally selected only on the basis of their frequency in human populations, were found to share largely overlapping peptide motifs. Testing panels of known DP epitopes and a panel of peptides spanning a set of Phleum pratense Ags revealed that these molecules also share largely overlapping peptide-binding repertoires. This demonstrates that a previously hypothesized DP supertype extends far beyond what was originally envisioned and includes at least three additional very common DP specificities. Taken together, these DP supertype molecules are found in >90% of the human population. Thus, these findings have important implications for epitope-identification studies and monitoring of human class II-restricted immune responses.
Conflict of interest statement
The authors have no financial conflicts of interest.
Figures



Similar articles
-
HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity.J Immunol. 2002 Dec 15;169(12):6928-34. doi: 10.4049/jimmunol.169.12.6928. J Immunol. 2002. PMID: 12471126
-
Divergent motifs but overlapping binding repertoires of six HLA-DQ molecules frequently expressed in the worldwide human population.J Immunol. 2010 Oct 1;185(7):4189-98. doi: 10.4049/jimmunol.1001006. Epub 2010 Sep 1. J Immunol. 2010. PMID: 20810981 Free PMC article.
-
Characterizing the binding motifs of 11 common human HLA-DP and HLA-DQ molecules using NNAlign.Immunology. 2012 Jul;136(3):306-11. doi: 10.1111/j.1365-2567.2012.03579.x. Immunology. 2012. PMID: 22352343 Free PMC article.
-
HLA-DRB1, -DQB1 and -DPB1 polymorphism in the Slovak population.Tissue Antigens. 1998 May;51(5):574-6. doi: 10.1111/j.1399-0039.1998.tb02996.x. Tissue Antigens. 1998. PMID: 9672160
-
Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes.Immunogenetics. 2011 Jun;63(6):325-35. doi: 10.1007/s00251-011-0513-0. Epub 2011 Feb 9. Immunogenetics. 2011. PMID: 21305276 Free PMC article.
Cited by
-
Designing Multi-Antigen Vaccines Against Acinetobacter baumannii Using Systemic Approaches.Front Immunol. 2021 Apr 16;12:666742. doi: 10.3389/fimmu.2021.666742. eCollection 2021. Front Immunol. 2021. PMID: 33936107 Free PMC article.
-
Characterization of Conserved and Promiscuous Human Rhinovirus CD4 T Cell Epitopes.Cells. 2021 Sep 2;10(9):2294. doi: 10.3390/cells10092294. Cells. 2021. PMID: 34571943 Free PMC article.
-
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.Mol Ther. 2021 Mar 3;29(3):1199-1213. doi: 10.1016/j.ymthe.2020.11.019. Epub 2020 Nov 17. Mol Ther. 2021. PMID: 33212301 Free PMC article.
-
Assay format diversity in pre-clinical immunogenicity risk assessment: Toward a possible harmonization of antigenicity assays.MAbs. 2022 Jan-Dec;14(1):1993522. doi: 10.1080/19420862.2021.1993522. MAbs. 2022. PMID: 34923896 Free PMC article. Review.
-
Definition of CD4 Immunosignatures Associated with MTB.Front Immunol. 2014 Mar 24;5:124. doi: 10.3389/fimmu.2014.00124. eCollection 2014. Front Immunol. 2014. PMID: 24715893 Free PMC article. Review.
References
-
- Doherty PC, Zinkernagel RM. A biological role for the major histocompatibility antigens. Lancet. 1975;1:1406–1409. - PubMed
-
- Zinkernagel RM, Doherty PC. The discovery of MHC restriction. Immunol Today. 1997;18:14–17. - PubMed
-
- Klein J. Natural History of the Major Histocompatibility Complex. Wiley; New York: 1986.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials